TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search results
As top-ranking BRIN officials began their work on downsizing the Eijkman Institute, founded in 1888 and named after Dutch physician Christiaan Eijkman who is credited for discovering Beriberi, the research agency has been conducting research to develop the locally-sourced Merah Putih vaccine, one of the candidates for the government’s booster shot rollout. Work on the vaccine is expected to wrap up in late January.
A presidential regulation on the National Research Agency (BRIN) mandates the agency to have a steering committee led by the head of the Agency for Pancasila Ideology Education's (BPIP) steering committee -- a position held by Indonesian Democratic Party of Struggle (PDI-P) leader Megawati Soekarnoputri.
Indonesia's bid to develop its own coronavirus vaccines either is marred with questionable trials backed by politicians or government plans to dissolve the research ministry that has helmed the country's vaccine consortium.
